4//SEC Filing
Pridgen William 4
Accession 0001415889-22-003314
CIK 0001818844other
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 2:52 PM ET
Size
6.3 KB
Accession
0001415889-22-003314
Insider Transaction Report
Form 4
Pridgen William
Director
Transactions
- Purchase
Common Stock
2022-03-23$5.46/sh+2,197$12,002→ 22,419 total(indirect: 401 (k) Account)
Holdings
- 709,234
Common Stock
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.37 to $5.48, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. ("Virios"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
- [F2]Reflects corrected holdings, as prior reports incorrectly understated indirect holdings and overstated direct holdings, by 1,500 shares.
- [F3]The number of shares reported are indirectly held within the Reporting Person's 401(k) account and are invested in the Tuscaloosa Surgical Assoc PC 401k U/A Dtd Jan 1, 2001 of which the Reporting Person is trustee.
Documents
Issuer
Virios Therapeutics, Inc.
CIK 0001818844
Entity typeother
Related Parties
1- filerCIK 0001826115
Filing Metadata
- Form type
- 4
- Filed
- Mar 23, 8:00 PM ET
- Accepted
- Mar 24, 2:52 PM ET
- Size
- 6.3 KB